Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

November 29, 2014

Scientific spotlights from the ISMH

Colored MRI showing a prostate cancer seen as a colored spot at centre Recent scientific spotlights from the International Society of Men’s Health (ISMH)   Testicular Cancer Screening Update1 The United States Preventive Services Task Force (USPSTF) recently published its updated guidelines on testicular cancer screening. Confirming their previous recommendations from 2004, the USPSTF states […]

Men’s health in Ireland – Facts and Figures

According to the report ‘Women and Men in Ireland 2010’ published last February by the Central Statistical Office, Ireland along with Malta and Sweden had the most gender-balanced populations in the EU in 2009 with 99 men per 100 women.  Key fact and figures from the report include: Life expectancy Life expectancy for men in […]

Bisphosphonates – risk of atypical femoral fracture

Bisphosphonates* are a class of medicines which inhibit osteoclast mediated bone resorption and are indicated in certain malignant and benign diseases, including prophylaxis and treatment of osteoporosis. In 2008, a European review concluded that the available data supported an association between alendronate and atypical stress fractures of the femur and the product information for alendronate […]

Self-Administration Label for Firazyr approved

European Commission Approves Self-Administration Label for Firazyr (icatibant) for the Symptomatic Treatment of Acute Hereditary Angioedema Attacks. PDF (568KB) Shire has announced that the European Commission has approved Firazyr (icatibant) for self-administration after training in subcutaneous injection technique by a healthcare professional. Icatibant is the first and only subcutaneous treatment for acute Type I and […]

Arizime

Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil HCl (monohydrate) 5mg, 10mg. Description: White or almost white, round, biconvex film-coated tablets. 5mg: Marked E 381 on one side. 10mg: Marked E382 on one side. Presentations: 5mg-28, €29.62; 10mg-28, €41.52. Indication: Symptomatic treatment of mild to moderately severe Alzheimer’s dementia. Pharmacology: […]

Brinavess

Company: MSD. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Vernakalant (HCl) 20mg/ml. Description: Concentrate for solution for infusion. Presentation: 25ml vial. Price available upon request. Indications: Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. Non-surgery patients, atrial fibrillation ≤7 days duration. Post-cardiac surgery patients, atrial fibrillation ≤3 days duration. Pharmacology: […]

Levocetirizine Teva

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Levocetirizine diHCl 5mg. Description: White to off white, film coated oval shaped tablet marked LC5 on one side. Presentation: 28, €6.63. Indications: Symptomatic treatment of perennial allergic rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria. Pharmacology: Levocetirizine, the (R) enantiomer of cetirizine, is […]

Palexia

Company: Grünenthal Pharma Ltd. Legal category: Controlled drug. Sport permitted. Active ingredient: Tapentadol (HCl) 50mg, 75mg. Description: Resp. white or pale yellow round film-coated tablets, marked with Grünenthal logo on one side and H6 or H7, resp., on the other side. Presentations: 50mg-28, €14.70; 50mg-56, €29.40; 75mg-28, €22.05; 75mg-56, €44.10. Indication: Relief of moderate to […]

Palexia SR

Company: Grünenthal Pharma Ltd. Legal category: Controlled drug. Sport permitted. Active ingredient: Tapentadol (HCl) 50mg, 100mg, 150mg, 200mg, 250mg. Description: Resp. white, pale yellow, pale pink, pale orange or brownish red film-coated oblong prolonged-release tablets marked with Grünenthal logo on one side and H1, H2, H3, H4 or H5, resp., on the other side. Presentations: […]

Saflutan

Company: MSD. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Tafluprost 15μg/ml Description: Clear, colourless solution in single dose containers. Presentation: 0.3ml-30, €19.50. Indications: Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension. As monotherapy in patients who would benefit from preservative free eye drops, in patients insufficiently responsive to first-line therapy, […]

Next Page »